<DOC>
	<DOC>NCT00456677</DOC>
	<brief_summary>Trial of effects of minocycline as "add-on" therapy to adults with asthma with a history of requiring at least one episode of oral steroid therapy to control the disease.</brief_summary>
	<brief_title>Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma</brief_title>
	<detailed_description>This is a double-blind, placebo-controlled crossover study of adult asthmatics given minocycline 150 mg po BID or placebo as add-on therapy for eight weeks each. Each eight week arm is separated by a four week wash-out. Spirometry is performed at the baseline and end of each arm. Daily symptoms scores, peak flow rates, and oral steroid requirements are recorded. A standardized asthma quality of life symptoms assessment is made every four weeks (AQLQ, Juniper).</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Adult asthmatics History of or current use of oral steroids to control symptoms Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>minocycline</keyword>
	<keyword>asthma</keyword>
	<keyword>oral corticosteroids</keyword>
</DOC>